Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics.

We help clients navigate complex product development and commercialization issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments. Our deep content experience, combined with our collaborative and hands-on approach results in practical solutions that drive internal alignment at the corporate, portfolio, and brand levels.


Check out our blog for news and commentary on the latest issues in pharma.



Immunotherapy in Oncology September 2015
Immuno-Oncology Brings New Opportunites for Developers of Targeted Cytotoxics


IN VIVO August 2014
WHEN ILLUMINA BUYS ROCHE: The Dawning of the Era of Diagnostics Dominance